SCHEMBL30677196

SCHEMBL30677196

N#Cc1ccc(N/N=C/C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 1/20 0.47
MLYCD O95822 1/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 3/20 0.40
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
KIF11 P52732 2/20 0.39
SLC22A12 Q96S37 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
ABCC9 O60706 2/20 0.36
KCNJ11 Q14654 2/20 0.36
MAPT P10636 4/20 0.36
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1681931 0.76 GAA (0.46) HDAC1HDAC7HDAC8HTTSMN1; SMN2
SCHEMBL1681929 0.76 GAA (0.46) HDAC1HDAC7HDAC8HTTSMN1; SMN2
SCHEMBL10618433 0.75 NOX1 (0.52) CYP1B1HTTSMN1; SMN2ALDH1A1LMNA
SCHEMBL10618428 0.75 NOX1 (0.52) CYP1B1HTTSMN1; SMN2ALDH1A1LMNA
SCHEMBL21626722 0.70 GAA (0.59) CYP1B1HTTSMN1; SMN2ALDH1A1LMNA
SCHEMBL7325881 0.69 MEN1 (0.56) HTTSMN1; SMN2ALDH1A1LMNAKDM4E
SCHEMBL6132428 0.69 CYP1B1 (0.49) CYP1B1MLYCDHDAC1HDAC7HDAC8
SCHEMBL9529534 0.69 HTT (0.48) CYP1B1HDAC1HDAC7HDAC8HDAC6
SCHEMBL6132425 0.69 CYP1B1 (0.49) CYP1B1MLYCDHDAC1HDAC7HDAC8
SCHEMBL5360276 0.69 KIF11 (0.47) CYP1B1MLYCDHDAC1HDAC7HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543890-A1 USP1 INHIBITORS AND USES THEREOF Forma Therapeutics, Inc. (US) 2025-04-30 EP disclosed
WO-2023250084-A1 USP1 INHIBITORS AND USES THEREOF FORMA THERAPEUTICS, INC. (US) 2023-12-28 WO disclosed